Annual Gross Margin
89.59%
-2.62%-2.84%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual gross profit margin is 89.59%, with the most recent change of -2.62% (-2.84%) on December 31, 2023.
- During the last 3 years, RARE annual gross margin has fallen by -8.15% (-8.34%).
- RARE annual gross margin is now -10.37% below its all-time high of 99.96%, reached on December 31, 2017.
Performance
RARE Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
84.93%
-0.60%-0.70%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly gross profit margin is 84.93%, with the most recent change of -0.60% (-0.70%) on September 30, 2024.
- Over the past year, RARE quarterly gross margin has dropped by -3.86% (-4.35%).
- RARE quarterly gross margin is now -22.54% below its all-time high of 109.65%, reached on March 31, 2020.
Performance
RARE Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
RARE Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.8% | -4.3% |
| 3 y3 years | -8.3% | -10.5% |
| 5 y5 years | -8.4% | -5.2% |
RARE Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.1% | at low | -11.3% | +1.2% |
| 5 y | 5-year | -8.3% | at low | -22.5% | +1.2% |
| alltime | all time | -10.4% | at low | -22.5% | +1.2% |
Ultragenyx Pharmaceutical Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 84.93%(-0.7%) |
| Jun 2024 | - | 85.53%(+2.0%) |
| Mar 2024 | - | 83.89%(-7.3%) |
| Dec 2023 | 89.59%(-2.8%) | 90.54%(+2.0%) |
| Sep 2023 | - | 88.79%(-2.3%) |
| Jun 2023 | - | 90.85%(+3.5%) |
| Mar 2023 | - | 87.80%(-7.4%) |
| Dec 2022 | 92.21%(-3.4%) | 94.85%(+4.8%) |
| Sep 2022 | - | 90.48%(-0.3%) |
| Jun 2022 | - | 90.74%(-1.8%) |
| Mar 2022 | - | 92.37%(-3.6%) |
| Dec 2021 | 95.44% | 95.79%(+0.9%) |
| Sep 2021 | - | 94.89%(-1.6%) |
| Jun 2021 | - | 96.39%(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 94.78%(+0.8%) |
| Dec 2020 | 97.74%(+7.0%) | 94.01%(-3.2%) |
| Sep 2020 | - | 97.12%(+0.0%) |
| Jun 2020 | - | 97.08%(-11.5%) |
| Mar 2020 | - | 109.65%(+28.0%) |
| Dec 2019 | 91.31%(-6.6%) | 85.65%(-4.4%) |
| Sep 2019 | - | 89.60%(-7.5%) |
| Jun 2019 | - | 96.83%(-0.7%) |
| Mar 2019 | - | 97.51%(+0.7%) |
| Dec 2018 | 97.77%(-2.2%) | 96.88%(-0.8%) |
| Sep 2018 | - | 97.68%(-1.2%) |
| Jun 2018 | - | 98.90%(+1.0%) |
| Mar 2018 | - | 97.89%(-2.1%) |
| Dec 2017 | 99.96% | 99.96% |
FAQ
- What is Ultragenyx Pharmaceutical annual gross profit margin?
- What is the all time high annual gross margin for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual gross margin year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly gross profit margin?
- What is the all time high quarterly gross margin for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly gross margin year-on-year change?
What is Ultragenyx Pharmaceutical annual gross profit margin?
The current annual gross margin of RARE is 89.59%
What is the all time high annual gross margin for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual gross profit margin is 99.96%
What is Ultragenyx Pharmaceutical annual gross margin year-on-year change?
Over the past year, RARE annual gross profit margin has changed by -2.62% (-2.84%)
What is Ultragenyx Pharmaceutical quarterly gross profit margin?
The current quarterly gross margin of RARE is 84.93%
What is the all time high quarterly gross margin for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly gross profit margin is 109.65%
What is Ultragenyx Pharmaceutical quarterly gross margin year-on-year change?
Over the past year, RARE quarterly gross profit margin has changed by -3.86% (-4.35%)